HAEMONETICS ANTICOAGULANT CITRATE DEXTROSE SOLUTION — anhydrous citric acid, trisodium citrate dihydrate and dextrose monohydrate solution
500 mL for use only with automated apheresis devices Each 100 mL contains Citric Acid (anhydrous), USP 0.73 g Sodium Citrate (hydrous), USP 2.20 g Dextrose (hydrous), USP 2.45 g
Not for direct intravenous infusion. Do not use unless solution is clear and no leaks detected. Single use container. Discard unused portion. Sterile, pyrogen free solution. Rx only.
Room temperature (25 degree C/77 degree F). Avoid excessive heat. Protect from freezing.
L331-01 Product code 426A Haemonetics Corporation Braintree, MA 02184 USA Lot No. Exp. Date
HAEMONETICS ANTICOAGULANT CITRATE DEXTROSE SOLUTION, USP, FORMULA A (ACDA) 500 mL Haemonetics Corporation
| HAEMONETICS ANTICOAGULANT CITRATE DEXTROSE SOLUTION |
anhydrous citric acid, trisodium citrate dihydrate, dextrose monohydrate solution
|Labeler — Haemonetics Corporation (057827420)|
|Haemonetics Corporation||942344649||manufacture (57826-426)|
Revised: 12/2019 Haemonetics Corporation
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.